Received Jan 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
she was tired and weak, but is not sure when that started; she was tired and weak, but is not sure when that started; The patient reports that her fever reoccurred, but had no other symptoms; Did not eat much; Fever; she experienced Nausea on Wednesday; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included breast cancer (Breast Cancer survivor (pre-existing Shingrix)). Previously administered products included Shingrix (first dose received on unknown date). Concomitant products included paracetamol (Tylenol). On 05-JAN-2026 18:30, the patient received the 2nd dose of Shingrix. On 06-JAN-2026, 1 days after receiving Shingrix, the patient experienced fever (Verbatim: Fever). On 07-JAN-2026, the patient experienced nausea (Verbatim: she experienced Nausea on Wednesday) and decreased appetite (Verbatim: Did not eat much). On 17-JAN-2026, the patient experienced fever (Verbatim: The patient reports that her fever reoccurred, but had no other symptoms). On an unknown date, the patient experienced tiredness (Verbatim: she was tired and weak, but is not sure when that started) and weakness (Verbatim: she was tired and weak, but is not sure when that started). On 07-JAN-2026, the outcome of the fever was resolved (duration 1 day). On 10-JAN-2026, the outcome of the tiredness and weakness were resolved. The outcome of the nausea was resolved (duration 2 days) and the outcome of the decreased appetite was unknown and the outcome of the fever was not reported. It was unknown if the reporter considered the fever, tiredness, weakness, nausea, decreased appetite and fever to be related to Shingrix. It was unknown if the company considered the fever, tiredness, weakness, nausea, decreased appetite and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 22-JAN-2026 The patient self-reported this case. The reporter mentioned that the patient had the breast cancer puts the patient's immune system in a different place, and body does not like vaccinations as a result, and the got feverish, covid, flu after vaccinations, precautionary the patient took Tylenol before the Shingrix vaccine. The batch number was not provided and a request for this information has been made.
Medical History/Concurrent Conditions: Breast cancer (Breast Cancer survivor (pre-existing Shingrix))
TYLENOL
Test Date: 20260106; Test Name: Body temperature; Result Unstructured Data: (Test Result:101.1,Unit:degree F,Normal Low:,Normal High:); Test Date: 20260106; Test Name: Body temperature; Result Unstructured Data: (Test Result:101.4,Unit:degree F,Normal Low:,Normal High:); Test Date: 20260107; Test Name: Body temperature; Result Unstructured Data: (Test Result:98.9,Unit:degree F,Normal Low:,Normal High:)